Actively Recruiting
Preimplantation Genetic Testing for Aneuploidies in Patients With Recurrent Implantation Failure
Led by Universitaire Ziekenhuizen KU Leuven · Updated on 2025-02-26
100
Participants Needed
1
Research Sites
400 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Assessing whether Preimplantation Genetic Testing for Aneuploidy (PGT-A) can increase the ongoing pregnancy rate per transferred embryo and can decrease the time to pregnancy and miscarriage rate in patients with Recurrent Implantation Failure (RIF)
CONDITIONS
Official Title
Preimplantation Genetic Testing for Aneuploidies in Patients With Recurrent Implantation Failure
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Women with recurrent implantation failure (previous transfer of least 4 good quality embryos in at least 3 fresh or frozen cycles)
- BMI < 35
- Normal hysteroscopy
You will not qualify if you...
- Thin endometrium in previous cycles (<6mm)
- Endometriosis ASRM score III-IV
- Premature ovarian failure (POF, Bologna criteria)
- Abnormal karyotype
- Use of donor oocytes or embryos
- Preimplantation Genetic Testing for Monogenic Disorders (PGT-M)
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
UZ Leuven
Leuven, Belgium, 3000
Actively Recruiting
Research Team
M
Myriam Welkenhuysen
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here